Bone Graft Materials for Wound Healing After Tooth Extraction
Trial Summary
What is the purpose of this trial?
The primary aim of the study is to determine the amount of newly formed vital bone, residual graft material, and "connective tissue/other" 18 to 20 weeks after ridge preservation is performed using DFDBA fibers alone, DFDBA particulate alone, a combination of xenograft and DFDBA particulate, or a combination of xenograft and DFDBA fibers.
Research Team
Brian L Mealey, DDS, MS
Principal Investigator
University of Texas Health Science Center San Antonio
Angela Palaiologou-Gallis, DDS
Principal Investigator
University of Texas Health Science Center San Antonio
Eligibility Criteria
This trial is for non-pregnant women, including those post-hysterectomy, tubal ligation, or menopause. Participants should be nonsmokers or light smokers (less than 10 cigarettes per day), have a tooth excluding molars needing extraction with enough bone height and space for an implant. Those with active infections other than periodontitis, heavy smokers, certain medical conditions affecting healing, or on specific medications are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Tooth extraction and ridge preservation using DFDBA fibers alone, DFDBA particulate alone, a combination of xenograft and DFDBA particulate, or a combination of xenograft and DFDBA fibers
Healing
Participants undergo a healing period following ridge preservation, during which they are monitored as needed per standard care
Follow-up
Participants are monitored for safety and effectiveness after treatment, including core biopsy evaluation and measurement of clinical outcomes
Treatment Details
Interventions
- Ridge Preservation
- Vallomix
- Vallomix-F
- Vallos
- Vallos-F
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center at San Antonio
Lead Sponsor